Short Interest in CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Expands By 21.3%

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 17,100 shares, a growth of 21.3% from the September 15th total of 14,100 shares. Based on an average daily volume of 25,900 shares, the days-to-cover ratio is currently 0.7 days.

CERo Therapeutics Price Performance

Shares of NASDAQ:CEROW opened at $0.01 on Wednesday. The business has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.04. CERo Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.25.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.